Generics 20

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Diltiazem manufacturers

20 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

20 products found

diltiazem

Tablets, film coated 30 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
Manufacturer #22627
This pharmaceutical company was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 4 days

diltiazem

Tablets 60 mg, 90 mg, 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19223
This Asian-based company is a leading manufacturer of dermatological and cosmeceutical products with a presence in over 50 countries across the EU, North America, and other regions. With over four decades of experience, they offer a wide range of prescription and over-the-counter medications, as well as cosmetic products. Key therapy areas include skin ailments, with principal dosage forms including creams, lotions, tablets, capsules, and liquids. Their WHO-GMP accredited facilities ensure international standards in production. The company also manufactures generics for various therapeutic areas and offers a dedicated baby care line.

Manufacturer usually replies in 4 days

diltiazem

Tablets 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18431
This pharmaceutical company, a leader in India since the 1970s, focuses on producing high-quality medications for global markets. Their portfolio includes prescription drugs and over-the-counter medicines spanning key therapy areas such as cardiology, psychiatry, gastrointestinal disorders, and diabetes management. They specialize in dosage forms like tablets, capsules, syrups, dry syrups, and suspensions. The company boasts a large production facility with separate areas for manufacturing, storage, and non-production activities. Their ISO and WHO-GMP certifications ensure adherence to strict quality standards. They have a skilled team of professionals with over 40 years of experience in the healthcare industry.

Manufacturer usually replies in 1 days

Want to see all 20 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Diltiazem Manufacturers

Diltiazem treats high blood pressure or hypertension and prevents episodes of chest pain also called Angina. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Regular use of Diltiazem leads to a significant decrease in the number and severity and the number of episodes of chest pain from angina. It may help increase your ability to exercise. Diltiazem is used to prevent chest pain (angina). It may help to increase your ability to exercise and decrease how often you may get angina attacks. Diltiazem is called a calcium channel blocker. Diltiazem actions relax blood vessels in the body and heart. This lowers the heart rate so that blood can flow more easily. This results in less stress on the heart, making it less susceptible to cardiovascular issues. Diltiazem is called a calcium channel blocker. Diltiazem is sold under the brand names such as Cardizem, Cardizem LA, Cartia XT among others. Bayer AG started the development of calcium channel blockers in the 1970s. Diltiazem is one of the several other calcium channel blockers developed by them in the 70s. Valeant International Bermuda is the current assignee who has made a formulation suitable for one a day administration. Diltiazem is available as tablets. These are to be swallowed whole. The users should not split, crush, or chew the tablet. It is sold in increasing strengths of 30-mg,60-mg, 90-mg, 120- mg scored tablets and are supplied in bottles of 100 tablets. Dosage must be adjusted to each patient's needs. The initial starting is 30 mg, given four times daily, before meals and at bedtime. If there is a need, does increase should happen gradually, so it is administered in divided doses, three or four times daily. This is done at 1-to 2-day intervals till the users get an optimum response. The average optimum dosage range is between 180 to 360 mg/day.

How does Diltiazem work?

It is not known exactly how its antianginal action function, however, it is described that it works on Angina through a Coronary Artery Spasm. It is a potent dilator of both epicardial and subendocardial coronary arteries. It induces Spontaneous and ergonovine-induced coronary artery spasms. In users with Exertional Angina, it increases users' exercise tolerance, because it can reduce myocardial oxygen demand. This is accomplished via reductions in heart rate and systemic blood pressure at submaximal and maximal exercise workloads.

The Cost of Diltiazem

An online search for the wholesale price for sale of Diltiazem for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. In the USA, the consumers have to pay an average retail price of $28.09 for 90 tablets of 30mg. whereas in India, the cost of 90 tablets is only USD 6.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Diltiazem distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Diltiazem suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Diltiazem. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Diltiazem is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Diltiazem suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Diltiazem Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation